• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小儿年龄组中与Vogt-小柳-原田病相关的葡萄膜炎的长期预后

Long-term Outcomes of Uveitis Associated with Vogt-Koyanagi-Harada Disease in the Pediatric Age Group.

作者信息

AlBloushi Abdulrahman F, AlEnezi Saad H, Al Owaifeer Adi Mohammed, Al-Hadlaq Omar S, Gikandi Priscilla W, Abu El-Asrar Ahmed M

机构信息

Department of Ophthalmology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.

Ophthalmology Department, College of Medicine, Majmaah University, Al Majma'ah, Saudi Arabia.

出版信息

Ocul Immunol Inflamm. 2022 Oct-Nov;30(7-8):1669-1677. doi: 10.1080/09273948.2021.1933074. Epub 2021 Jun 29.

DOI:10.1080/09273948.2021.1933074
PMID:34184966
Abstract

PURPOSE

To investigate the outcomes of uveitis associated with Vogt-Koyanagi-Harada (VKH) disease in pediatric age group (aged 16 years and under).

METHODS

A retrospective review of patients with VKH disease.

RESULTS

Among the 244 patients identified, 38 (76 eyes) were children. Among them, five had insulin-dependent diabetes mellitus. 21 presented with initial-onset acute disease and 17 with chronic recurrent disease. The mean follow-up period was 59.1 months. At presentation, chronic recurrent disease was associated with more severe inflammation as indicated by the presence of mutton-fat keratic precipitates ( < .001), iris nodules ( = .005) and posterior synechiae ( < .001). During follow-up, the rate of complications was higher in children with chronic recurrent disease compared with initial-onset acute disease ( < .001). 92.4% of the eyes with initial-onset acute disease achieved a final visual acuity of ≥20/40 compared with 70.6% of the eyes with chronic recurrent disease ( = .013).

CONCLUSIONS

Chronic recurrent VKH disease in children is associated with worse outcomes.

摘要

目的

研究小儿年龄组(16岁及以下)与葡萄膜大脑炎(VKH)相关的葡萄膜炎的治疗结果。

方法

对VKH疾病患者进行回顾性研究。

结果

在确定的244例患者中,38例(76只眼)为儿童。其中,5例患有胰岛素依赖型糖尿病。21例表现为初发性急性疾病,17例表现为慢性复发性疾病。平均随访期为59.1个月。就诊时,慢性复发性疾病与更严重的炎症相关,表现为羊脂状角膜后沉着物(<.001)、虹膜结节(=.005)和虹膜后粘连(<.001)。随访期间,慢性复发性疾病患儿的并发症发生率高于初发性急性疾病患儿(<.001)。初发性急性疾病患儿92.4%的患眼最终视力达到≥20/40,而慢性复发性疾病患儿患眼的这一比例为70.6%(=.013)。

结论

儿童慢性复发性VKH疾病的治疗结果较差。

相似文献

1
Long-term Outcomes of Uveitis Associated with Vogt-Koyanagi-Harada Disease in the Pediatric Age Group.小儿年龄组中与Vogt-小柳-原田病相关的葡萄膜炎的长期预后
Ocul Immunol Inflamm. 2022 Oct-Nov;30(7-8):1669-1677. doi: 10.1080/09273948.2021.1933074. Epub 2021 Jun 29.
2
Prognostic factors for clinical outcomes in patients with Vogt-Koyanagi-Harada disease treated with high-dose corticosteroids.大剂量皮质类固醇治疗 Vogt-Koyanagi-Harada 病患者的临床转归的预后因素。
Acta Ophthalmol. 2013 Sep;91(6):e486-93. doi: 10.1111/aos.12127. Epub 2013 Apr 10.
3
Incidence, Risk Factors and Surgical Outcomes of Cataract among Patients with Vogt-Koyanagi-Harada Disease.Vogt-小柳-原田病患者白内障的发生率、危险因素和手术结果。
Ocul Immunol Inflamm. 2021 Jan 2;29(1):128-136. doi: 10.1080/09273948.2019.1668430. Epub 2019 Oct 22.
4
Outcomes of initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease occurred during pregnancy.与Vogt-小柳-原田病相关的初发性急性葡萄膜炎在妊娠期间出现的结局。
Int Ophthalmol. 2023 Jan;43(1):185-195. doi: 10.1007/s10792-022-02415-1. Epub 2022 Aug 9.
5
Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of 'sunset glow fundus' in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease.霉酚酸酯联合全身用糖皮质激素可预防与Vogt-小柳-原田病相关的初发性急性葡萄膜炎进展为慢性复发性炎症和“晚霞眼底”的形成。
Acta Ophthalmol. 2017 Feb;95(1):85-90. doi: 10.1111/aos.13189. Epub 2016 Aug 18.
6
Chronic Recurrent Vogt-Koyanagi-Harada Disease and Development of 'Sunset Glow Fundus' Predict Worse Retinal Sensitivity.慢性复发性伏格特-小柳-原田病及“晚霞样眼底”的出现预示视网膜敏感性更差。
Ocul Immunol Inflamm. 2017 Aug;25(4):475-485. doi: 10.3109/09273948.2016.1139730. Epub 2016 Mar 22.
7
Predictive factors and adalimumab efficacy in managing chronic recurrence Vogt-Koyanagi-Harada disease.预测因素与阿达木单抗治疗慢性复发性 Vogt-Koyanagi-Harada 病的疗效。
BMC Ophthalmol. 2024 Jun 7;24(1):238. doi: 10.1186/s12886-024-03511-9.
8
Prognostic factors in Vogt-Koyanagi-Harada disease.伏格特-小柳-原田病的预后因素
Int Ophthalmol. 2007 Apr-Jun;27(2-3):201-10. doi: 10.1007/s10792-007-9062-9. Epub 2007 Apr 14.
9
High prevalence of angle-closure glaucoma in Vogt-Koyanagi-Harada disease.Vogt-Koyanagi-Harada 病中闭角型青光眼的高发率。
Int Ophthalmol. 2022 Dec;42(12):3913-3921. doi: 10.1007/s10792-022-02412-4. Epub 2022 Jul 5.
10
Prognostic value of pretreatment indocyanine green angiography in the acute uveitic phase of Vogt-Koyanagi-Harada disease.Vogt-小柳原田病急性期前吲哚菁绿血管造影的预后价值。
Acta Ophthalmol. 2024 Aug;102(5):e679-e686. doi: 10.1111/aos.16613. Epub 2023 Dec 22.

引用本文的文献

1
[Recurrent chronic Vogt-Koyanagi-Harada syndrome or sarcoidosis? A Gloomy diagnosis].[复发性慢性葡萄膜大脑炎综合征还是结节病?一个令人沮丧的诊断]
Rev Med Inst Mex Seguro Soc. 2023 Sep 4;61(5):702-706. doi: 10.5281/zenodo.8316491.
2
An Overview of Pediatric Uveitis.小儿葡萄膜炎概述
Turk Arch Pediatr. 2023 Jul;58(4):363-370. doi: 10.5152/TurkArchPediatr.2023.23086.